US Bancorp DE Has $85,000 Stock Position in The Chemours Company (NYSE:CC)

US Bancorp DE lowered its holdings in shares of The Chemours Company (NYSE:CC) by 21.9% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 5,028 shares of the specialty chemicals company’s stock after selling 1,408 shares during the period. US Bancorp DE’s holdings in Chemours were worth $85,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Strategic Financial Concepts LLC bought a new position in Chemours in the 4th quarter valued at about $357,000. Vision One Management Partners LP acquired a new position in shares of Chemours in the third quarter valued at approximately $28,252,000. Two Sigma Advisers LP increased its stake in shares of Chemours by 9.4% during the third quarter. Two Sigma Advisers LP now owns 503,100 shares of the specialty chemicals company’s stock worth $10,223,000 after purchasing an additional 43,200 shares during the period. Entropy Technologies LP acquired a new stake in Chemours during the 4th quarter worth approximately $266,000. Finally, Twelve Points Wealth Management LLC boosted its stake in Chemours by 42.8% in the 4th quarter. Twelve Points Wealth Management LLC now owns 78,325 shares of the specialty chemicals company’s stock valued at $1,324,000 after purchasing an additional 23,490 shares during the period. 76.26% of the stock is currently owned by institutional investors.

Chemours Stock Performance

NYSE CC opened at $14.59 on Tuesday. The firm’s fifty day moving average price is $17.17 and its two-hundred day moving average price is $18.45. The stock has a market cap of $2.18 billion, a PE ratio of 25.60 and a beta of 2.00. The company has a debt-to-equity ratio of 6.70, a quick ratio of 0.92 and a current ratio of 1.68. The Chemours Company has a fifty-two week low of $13.09 and a fifty-two week high of $29.21.

Chemours (NYSE:CC) last issued its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share for the quarter, topping analysts’ consensus estimates of $0.10 by $0.01. The business had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion. Chemours had a return on equity of 26.54% and a net margin of 1.51%. On average, equities analysts expect that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 6.85%. The ex-dividend date of this dividend was Friday, February 28th. Chemours’s dividend payout ratio is currently 175.44%.

Analyst Upgrades and Downgrades

CC has been the topic of several recent research reports. BMO Capital Markets lowered their price objective on Chemours from $34.00 to $27.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 19th. Morgan Stanley dropped their price objective on shares of Chemours from $25.00 to $22.00 and set an “equal weight” rating for the company in a research note on Monday, January 13th. Barclays decreased their target price on shares of Chemours from $23.00 to $19.00 and set an “equal weight” rating on the stock in a research report on Monday, February 24th. Mizuho reduced their target price on Chemours from $22.00 to $21.00 and set a “neutral” rating on the stock in a report on Tuesday, January 7th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $25.00 target price on shares of Chemours in a report on Thursday, December 12th. Five analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $23.11.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.